Citation Impact
Citing Papers
TFEB Links Autophagy to Lysosomal Biogenesis
2011 StandoutScience
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
2010 StandoutScience
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
2005 StandoutNobel
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
2007 StandoutNobel
Small Interfering RNA Targeted to Hepatitis C Virus 5′ NontranslatedRegion Exerts Potent Antiviral Effect
2006
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes
2010
Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy
2007
Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes
2007
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation
2012
Hepatitis C virus entry into host cells
2007
Topology of hepatitis C virus envelope glycoproteins
2003
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Role of lipid metabolism in hepatitis C virus assembly and entry
2009
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
2009 Standout
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Cell entry of hepatitis C virus
2006
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Decoding ALS: from genes to mechanism
2016 StandoutNature
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
The coming of age of de novo protein design
2016 StandoutNatureNobel
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Autophagy in Human Health and Disease
2013 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Hepatitis C Virus Entry
2007 StandoutNobel
Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes
2010
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
2010 StandoutNobel
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The Hallmarks of Aging
2013 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry
2010
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus
2006
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Membrane proteomics of phagosomes suggests a connection to autophagy
2008 StandoutNobel
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
2009
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells
2006
Hepatitis C Virus Infection Impairs IRF-7 Translocation and Alpha Interferon Synthesis in Immortalized Human Hepatocytes
2010
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
2006
Characterization of Functional Hepatitis C Virus Envelope Glycoproteins
2004
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Cellular and molecular biology of HCV infection and hepatitis
2009
Diverse CD81 Proteins Support Hepatitis C Virus Infection
2006 StandoutNobel
Future Therapies for Hepatitis C
2006
Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans
2015
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Membrane Morphology Is Actively Transformed by Covalent Binding of the Protein Atg8 to PE-Lipids
2014 StandoutNobel
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Works of Arnab Basu being referenced
Hepatitis C Virus Envelope Glycoproteins and Potential for Vaccine Development
2002
New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion
2013
Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric Glycoprotein
2002
Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes
2006
Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells
2007
Coexpression of Hepatitis C Virus E1 and E2 Chimeric Envelope Glycoproteins Displays Separable Ligand Sensitivity and Increases Pseudotype Infectious Titer
2004